СТЕСТВЕННЫЕ КИЛЛЕРЫ. ВЗГЛЯД РЕВМАТОЛОГА

1. <div><p>Herberman R.B., Nunn М.Е., Lavrin D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer, 1975,16,216-229.</p><p>Ferlazzo G., Munz C. NK cell compartments and their activation by dendritic cells. J. Immunol., 2004,172,1333-1339.</p><p>Janeway C.A., Travers P., Walport М., Shlomchik M. Immunobiology, 6th Edition, Garland Science Publishing, 2004, 89-91</p><p>Diefenbach A., Raulet D.H. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol. Rev., 2002,188,9-21.</p><p>Bukowski J. F., Woda B.A., Habu S. et al. Natural killer celldepletionenhancesvirussynthesisandvirus-induced hepatitis in vivo. J/lmmunoi, 1983,131,1531-1538.</p><p>Yu Y.Y., Kumar V., Bennett M. Murine natural killer cells and marrow graft rejection. Ann. Rev. Immunol., 1992,10,189-213.</p><p>Ljunggren H. G., Kdrre K. In search of the ‘missing self: MHC molecules and NK cell recognition.Immunol. Today., 1990,11,237-244.</p><p>Kim S., Poursine-Laurent J., Truscott S.M. et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature„ 2005,436,709- 713.</p><p>Moretta A., Bottino C., Mingari M.C. et al.What is a natural killer cell ? Nat. Immunol., 2002,3,6-8.</p><p>Moretta L., Biassoni R., Bottino C.,et al. Human NK cells and their receptors. Microbes. Infect., 2002,4,1539-1544</p><p>Moretta L., Moretta A. Killer immunologlobulin-like receptors. Curr. Opin. Immunol., 2004, 16, 626-633.</p><p>Raulet D.H., Vance R.E. Self-tolerance of natural killer cells. Nat. Rev. Immunol., 2006,6,520-531.</p><p>French, A.R., Yokoyama W.M. Natural killer cells and autoimmunity. Arthr. Res. Then, 2004,6,8-14.</p><p>Momot Т., Koch S., Hunzelmann N. el at. Association of killer cel! immunologlobulin-like receptors with scleroderma. Arthr. Rheum., 2004, 50,1561-1565.</p><p>Yen J.H., Moore B.E., Nakajima T. et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J. Exp. Med., 2001, 193,1159-1167.</p><p>Groh V., Bruhl A., El-Gabalawy H. et al. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Nat. Acad. Sci.USA, 2003, 100,9452-9457.</p><p>Silver R.M. Studies of rheumatoid synovial fluid lymphocytes. III. Phenotypic and Junctional analysis of natural killer-like cells. Clin. Immunol. Immunopathol., 1986, 39,159—167.</p><p>Combe B., Pope R., Darnell B., Tala I N. Modulation of natural killer cell activity in the rheumatoid joint and peripheral blood. Scand. J. Immunol., 1984,20,551-558.</p><p>Dalbeth N., Callan M.F. A subset of natural killer cells is greatly expanded within inflamed joints. Arthr. Rheum., 2002, 46,1763-1772.</p><p>Pridgeon C., Lennon G.P., Paz/nany L. et al. Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright, CD94bright, CD158negative phenotype. Rheumatology (Oxford), 2003, 42,870-878.</p><p>Fox D.A. The role of T cells in the immunopathogenesis of rheumatoid arthritis. Arthr. Rheum., 1997,40,598-609.</p><p>Zhang B., Yamamura Т. Kondo T. et al. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med., 1997, 186,1677-1687.</p><p>Smeltz R.B., Wolf N.A. Swanborg R.H. Inhibition of autoimmune T cell responses in the DA rat by bone marrow derived NK celts in vitm: implications for autoimmunity. J. Immunol., 1999,163,1390—1397.</p><p>Ciampolillo A., Guastamacchia E., Amati L. et at. Modifications of the immune responsiveness in patients with autoimmune thyroiditis: evidence for a systemic immune alteration. Curr. Pharm. Des., 2003, 9,1946-1950.</p><p>Cameron A.L., Kirby B., Griffiths C.E. Circulating natural killer cells in psoriasis. Br. J.Dermatol.,2003, 149,160-164.</p><p>O’Gorman М., Smith R., Garrison A. etal. Lymphocyte subsets in peripheral blood from newly diagnosed, untreated patients with juvenile dermatomyositis (JDM) are associated with disease activity scores (DAS). Arthr. Rheum., 2002, 46(suppl 9),S490.</p><p>Wouters C.H. Ceuppens J.L., Stevens E.A. Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis. Clin. Exp. Rheumatol., 2002, 20,239-248.</p><p>Yabuhara A., Yang F.C., Nakazawa T. et al. A killing defect of natural kilter cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J. Rheumatol., 1996,23,171-177.</p><p>Erkeller-Yusel F, Hulstaart F., Hannet I. et al. Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus, 1993, 2,227-231.</p><p>Kastrukoff L.F., Morgan N.G., Zecchini D. et al. A role for natural killer cells in the immunopathogenesis of multiple sclerosis. J. Neuroimmunol., 1998, 86,123-133.</p><p>Biron C.A., Byron K.S., Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med., 1989, 320,1731-1735.</p><p>Vanness E.R., Davis M.D., Tefferi A. Cutaneous findings associated with chronic natural killer cell lymphocytosis. Int. J. Dermatol., 2002,41,852-857.</p><p>Lamy Т., Loughran T.P. Jr. Clinical features of large granular lymphocyte leukemia. Semin. Hematol., 2003, 40,185-195.</p><p>Rabbani G.R., Phyliky R.L., Tefferi A. A long-term study of patients with chronic natural killer cell lymphocytosis. Br. J. Haematol., 1999, 106,960-966.</p><p>Orange J.S. Human natural killer cell deficiencies and susceptibility to injection. Microbes. Infect., 2002,4,1545-1558.</p></div><br />